BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
0.8870
+0.5340 (151.27%)
At close: May 7, 2026
BFNH Market Cap
BFNH has a market cap or net worth of $29.25 million as of May 8, 2026. Its market cap has decreased by -49.78% in one year.
Market Cap
29.25M
Enterprise Value
29.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.89
Market Cap Chart
Since February 24, 2006, BFNH's market cap has increased from 5.00M to 29.25M, an increase of 485.10%. That is a compound annual growth rate of 9.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 29.25M | 50.99% |
| Dec 29, 2025 | 19.38M | 93.83% |
| Dec 31, 2024 | 10.00M | -83.01% |
| Dec 29, 2023 | 58.84M | 1.01% |
| Dec 30, 2022 | 58.25M | 65.83% |
| Dec 30, 2021 | 35.13M | 215.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elamex SA de CV | 21.79M |
| Global Pharmatech | 20.76M |
| China Foods Holdings | 13.45M |
| House of Jane | 11.03M |
| NutraProducts | 10.06M |
| Glucose Health | 9.04M |
| Cellev8 Nutrition | 8.16M |
| Integrated BioPharma | 7.84M |